The effects of functional cake

Not Applicable

• Conditions: Condition 1: Metabolic Syndrome. Condition 2: Obesity.; Metabolic syndrome; Obesity due to excess calories; E88.81; E66.0

• Registration Number: IRCT20170506033836N2
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Age range 20 to 60 years
Body mass index (BMI) of 25–35 kg/m2
According to the ATP III definition, metabolic syndrome is present if three or more of the following five criteria are met: waist circumference over 102 cm (men) or 88 cm (women), blood pressure over 130/85 mmHg, fasting triglyceride (TG) level over 150 mg/dl, fasting high-density lipoprotein (HDL) cholesterol level less than 40 mg/dl (men) or 50 mg/dl (women) and fasting blood sugar over 100 mg/dl
Stable body weight (weight change less than 3 kg in the last 3 months)
Not participating in weight loss programs for the past 6 months

Exclusion Criteria

Diabetic patients receiving blood sugar-lowering drugs and insulin
History of alcohol consumption
Smoking
Pregnant and lactating women
People with mental illness, cancer, thyroid, cardiovascular, pulmonary, renal, hepatic, eating disorders
Taking drugs that affect appetite, body weight and lipid metabolism or have anti-inflammatory effect

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anthropometric measures. Timepoint: Before and after the intervention. Method of measurement: Bioelectric impedance analysis.;Blood pressure. Timepoint: Before and after the intervention. Method of measurement: digital sphygmomanometer.;Fasting blood sugar. Timepoint: Before and after the intervention. Method of measurement: Commercial kits.;Insulin. Timepoint: Before and after the intervention. Method of measurement: ELISA kit.;Insulin resistance index (HOMA-IR). Timepoint: Before and after the intervention. Method of measurement: Formula.;Lipids profile. Timepoint: Before and after the intervention. Method of measurement: Commercial kits.;Malon de aldehyde (MDA). Timepoint: Before and after the intervention. Method of measurement: Tubarbitoric acid method (TBARS).;C-reactive protein. Timepoint: Before and after the intervention. Method of measurement: ELISA kit.;Adiponectin. Timepoint: Before and after the intervention. Method of measurement: ELISA kit.